104 related articles for article (PubMed ID: 2138243)
1. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract][Full Text] [Related]
2. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
3. [Detection of point mutation of Kirsten ras oncogene in pancreatic carcinoma by polymerase chain reaction].
Motojima K; Kohara N; Furui J; Terada M; Tsunoda T; Nagata Y; Urano K
Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):453-8. PubMed ID: 1870574
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
5. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
6. ras oncogene p21 expression in hepatocellular carcinoma.
Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-myc and N-ras oncogenes in human hepatocellular carcinoma and pancreatic adenocarcinoma. A biochemical and immunocytochemical study.
Lin Y; Liu TH; Li SE
Chin Med J (Engl); 1988 Jul; 101(7):523-8. PubMed ID: 2852579
[No Abstract] [Full Text] [Related]
8. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
9. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
10. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
[TBL] [Abstract][Full Text] [Related]
13. [Oncogene products as tumor markers].
Shiku H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2212-7. PubMed ID: 3300559
[TBL] [Abstract][Full Text] [Related]
14. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
Li DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
17. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
[TBL] [Abstract][Full Text] [Related]
18. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
19. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
20. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]